Institutional ownership increased. 16mln purchases above $2 last quarter and only 3mln sales. Great names in there.
(If anyone has any doubt you can go over my previous posts) I posted previously that medical equipment sales takes time as there is existing manufacturer and hospitals need more than just FDA approval, which is hands on experience from other hospitals. We are social animals, we do what others do. ISRG had first mover advantage (econ101). TRXC will slowly eat them away.
TRXC has over 140mln dollars in the bank and no dilution beyond 2019. They are selling faster then preFDA. The more they sell the better Senhance will be sold. So far, 4 in over a year pre-FDA and just in 4 months after FDA approval they sold 4+. 4 for sure already sold. According to BOWA couples of more installations are coming. I talked to one rep, private messaging, he mentioned after Russian FDA approval (expected late March), they already have few pipelines lined up.
Current stock price action? Well I talked about it previously.
It is going down just because it is being heavily shorted not because people selling their positions. There is a major difference here. If it was naturally going down, I would be the first out of my position. Plus, Institutions are smarter then retail. Look at their Trading profits and you will understand what I am saying. There is a fallacy going around, oh Institutions don't make mistakes? Of course they do, they do much much much less than retail investors. I bet with institutions any time of the day, rather than against them.
I dont think current shorters are betting on TRXC demise. It is most likely let's short and accumulate at the bottom. I am really sorry for retail BEARs. Since they have absolutely 0 working thesis. Most likely war will be lost by them. Why? Because, TRXC sales are picking up month after month. FDA approval for more procedures. FL hospital guy posted on FB, how cool it was using Senhance. Surgeons love them. Plus per procedure cost is just 400 on stark contrast to competition. FDA said in their approval that Senhance is no less inferior to DaVinci. Enough said
I am pretty confident we will destroy the 2018 earnings estimate in just 2 quarters. Let's see in 3 months! This board will be transformed to Bulls!
